Hongjun Bian

918 total citations
29 papers, 699 citations indexed

About

Hongjun Bian is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Hongjun Bian has authored 29 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Epidemiology. Recurrent topics in Hongjun Bian's work include MicroRNA in disease regulation (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA Interference and Gene Delivery (4 papers). Hongjun Bian is often cited by papers focused on MicroRNA in disease regulation (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and RNA Interference and Gene Delivery (4 papers). Hongjun Bian collaborates with scholars based in China and United States. Hongjun Bian's co-authors include Jianni Qi, Xiaoping Ji, Juan Zhang, Xiaoxing Li, Chengyong Qin, Yun Zhang, Na Li, Yun Zhang, Wanhua Ren and Deya Shang and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Cellular and Molecular Life Sciences.

In The Last Decade

Hongjun Bian

28 papers receiving 695 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongjun Bian China 17 350 172 118 103 82 29 699
Baozhong Shen China 14 396 1.1× 259 1.5× 85 0.7× 56 0.5× 56 0.7× 16 859
M. Yamashita Japan 19 437 1.2× 86 0.5× 75 0.6× 46 0.4× 57 0.7× 57 959
Wen‐Chang Wang Taiwan 13 332 0.9× 197 1.1× 184 1.6× 13 0.1× 41 0.5× 55 759
Jiali Wei China 16 462 1.3× 335 1.9× 59 0.5× 25 0.2× 67 0.8× 70 880
Deborah A. Knight United States 14 315 0.9× 159 0.9× 100 0.8× 39 0.4× 137 1.7× 23 754
Yan Xue China 12 172 0.5× 47 0.3× 100 0.8× 62 0.6× 21 0.3× 42 626
Fang Yang China 15 323 0.9× 112 0.7× 79 0.7× 17 0.2× 30 0.4× 74 855
Wenyi Chen China 16 428 1.2× 227 1.3× 113 1.0× 24 0.2× 16 0.2× 50 933

Countries citing papers authored by Hongjun Bian

Since Specialization
Citations

This map shows the geographic impact of Hongjun Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjun Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjun Bian more than expected).

Fields of papers citing papers by Hongjun Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongjun Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjun Bian. The network helps show where Hongjun Bian may publish in the future.

Co-authorship network of co-authors of Hongjun Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Hongjun Bian. A scholar is included among the top collaborators of Hongjun Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongjun Bian. Hongjun Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bian, Hongjun, et al.. (2024). SH-Alb inhibits phenotype remodeling of pro-fibrotic macrophage to attenuate liver fibrosis through SIRT3-SOD2 axis. Biomedicine & Pharmacotherapy. 176. 116919–116919. 2 indexed citations
3.
Bian, Hongjun, et al.. (2024). Single-cell RNA-seq reveals the role of YAP1 in prefrontal cortex microglia in depression. BMC Neurology. 24(1). 191–191. 3 indexed citations
4.
Zhang, Wei, Xing‐Guo Zhang, Jinming Han, et al.. (2024). Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19. Frontiers in Pharmacology. 15. 1389187–1389187. 1 indexed citations
5.
Bian, Hongjun, et al.. (2023). The workload change and depression among emergency medical staff after the open policy during COVID-19: a cross-sectional survey in Shandong, China. Frontiers in Public Health. 11. 1281787–1281787. 2 indexed citations
6.
Jia, Huimin, et al.. (2023). Race between virus and inflammasomes: inhibition or escape, intervention and therapy. Frontiers in Cellular and Infection Microbiology. 13. 1173505–1173505. 4 indexed citations
7.
Tian, Miaomiao, Xiaoyu Xie, Tiantian Liu, et al.. (2023). Phosphorylation of RGS16 at Tyr168 promote HBeAg-mediated macrophage activation by ERK pathway to accelerate liver injury. Journal of Molecular Medicine. 102(2). 257–272. 2 indexed citations
8.
Tian, Miaomiao, Yan Ma, Tao Li, et al.. (2022). Functions of regulators of G protein signaling 16 in immunity, inflammation, and other diseases. Frontiers in Molecular Biosciences. 9. 962321–962321. 11 indexed citations
9.
Li, Jiaqi, Huimin Jia, Miaomiao Tian, et al.. (2022). SARS-CoV-2 and Emerging Variants: Unmasking Structure, Function, Infection, and Immune Escape Mechanisms. Frontiers in Cellular and Infection Microbiology. 12. 869832–869832. 19 indexed citations
10.
Xie, Xiaoyu, Chenxi Liu, Xiaonan Su, et al.. (2021). HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis. BMC Medicine. 19(1). 247–247. 42 indexed citations
11.
Zhou, Yi, Weiwu Ma, Hongjun Bian, et al.. (2020). Long non-coding RNA MIAT/miR-148b/PAPPA axis modifies cell proliferation and migration in ox-LDL-induced human aorta vascular smooth muscle cells. Life Sciences. 256. 117852–117852. 12 indexed citations
12.
Wang, Wenwen, Hongjun Bian, Feifei Li, et al.. (2018). HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines. Cellular and Molecular Life Sciences. 75(14). 2627–2641. 45 indexed citations
13.
Li, Feifei, Hongjun Bian, Wenwen Wang, et al.. (2018). HBV infection suppresses the expression of inflammatory macrophage miR‑210. Molecular Medicine Reports. 19(3). 1833–1839. 10 indexed citations
14.
Bian, Hongjun, Yi Zhou, Bin Yu, et al.. (2017). Rho-kinase signaling pathway promotes the expression of PARP to accelerate cardiomyocyte apoptosis in ischemia/reperfusion. Molecular Medicine Reports. 16(2). 2002–2008. 18 indexed citations
15.
Huang, Shouyue, et al.. (2017). Analysis of choroidal thickness in ocular hypertensive patients using enhanced depth imaging optical coherence tomography. Lasers in Medical Science. 33(1). 111–121. 3 indexed citations
16.
Bian, Hongjun, Feifei Li, Wenwen Wang, et al.. (2017). MAPK/p38 regulation of cytoskeleton rearrangement accelerates induction of macrophage activation by TLR4, but not TLR3. International Journal of Molecular Medicine. 40(5). 1495–1503. 20 indexed citations
17.
Pang, Xuehui, Hongjun Bian, Weijie Wang, et al.. (2016). A bio-chemical application of N-GQDs and g-C3N4 QDs sensitized TiO2 nanopillars for the quantitative detection of pcDNA3-HBV. Biosensors and Bioelectronics. 91. 456–464. 60 indexed citations
18.
Li, Bin, Rui Li, Chun Zhang, et al.. (2014). MicroRNA-7a/b Protects against Cardiac Myocyte Injury in Ischemia/Reperfusion by Targeting Poly(ADP-Ribose) Polymerase. PLoS ONE. 9(3). e90096–e90096. 56 indexed citations
19.
Li, Na, Hongjun Bian, Juan Zhang, et al.. (2010). The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clinica Chimica Acta. 411(23-24). 1963–1968. 80 indexed citations
20.
Zhang, Juan, Xiaoxing Li, Hongjun Bian, et al.. (2008). Inhibition of the activity of Rho-kinase reduces cardiomyocyte apoptosis in heart ischemia/reperfusion via suppressing JNK-mediated AIF translocation. Clinica Chimica Acta. 401(1-2). 76–80. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baozhong Shen Breakdown of academic impact, for papers by M. Yamashita Breakdown of academic impact, for papers by Wen‐Chang Wang Breakdown of academic impact, for papers by Jiali Wei Breakdown of academic impact, for papers by Deborah A. Knight Breakdown of academic impact, for papers by Yan Xue Breakdown of academic impact, for papers by Fang Yang Breakdown of academic impact, for papers by Wenyi Chen
Rankless by CCL
2026